2SEVENTY BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.95 USD | +3.99% |
|
+7.84% | +15.93% |
| 04-19 | US FDA mandates label updates on CAR-T cancer therapies | RE |
| 04-05 | Bristol-Myers Squibb, 2seventy Bio Say FDA Approves Expansion of Myeloma Treatment's Indication | MT |
Chart calendar 2seventy bio, Inc.
0fe016fc6761.60J1dGvJYEWn8qAFKr0jV9KUCscZk0A94-uiorjQB6o.vjZNTFjxGQ7ghY1AZNdKNqrFWqha8i5-grTEy8HkMv2TN00FMfgQNvaKlA~d210e3e44b1e9752414b2c5728944861
Upcoming events on 2seventy bio, Inc.
Past events on 2seventy bio, Inc.
| 14/03/2024 | Oncologic Drugs Advisory Committee Meeting |
| 13/03/2024 12:00 | Leerink Partners Global Biopharma Conference |
| 06/03/2024 19:10 | TD Cowen Health Care Conference |
| 05/03/2024 13:00 | Q4 2023 Earnings Call |
| 05/03/2024 12:00 | Q4 2023 Earnings Release |
| 22/02/2024 20:00 | Citi Oncology Leadership Summit |
| 08/02/2024 18:30 | Guggenheim Healthcare Talks Biotechnology Conference |
| 30/01/2024 13:00 | Business Update Call |
| 12/12/2023 13:00 | American Society of Hematology Meeting |
| 12/12/2023 00:45 | American Society of Hematology Meeting |
| 10/12/2023 01:30 | American Society of Hematology Meeting |
| 14/11/2023 13:00 | Q3 2023 Earnings Call |
| 14/11/2023 12:00 | Q3 2023 Earnings Release |
| 13/09/2023 20:35 | Morgan Stanley Global Healthcare Conference |
| 12/09/2023 13:00 | Business Update Call |
| 14/08/2023 13:00 | Q2 2023 Earnings Call |
| 14/08/2023 12:00 | Q2 2023 Earnings Release |
| 08/08/2023 13:00 | Wedbush PacGrow Healthcare Conference |
| 14/06/2023 23:20 | Goldman Sachs Global Healthcare Conference |
| 13/06/2023 13:30 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 54,5 55,2 -1.25% | 91,5 49,8 83.56% | 100 106 -5.23% | 88,6 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -298 -308 3.49% | -252 -276 8.93% | -227 -226 -0.79% | -131 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -314 -334 5.89% | -263 -298 11.63% | -238 -228 -4% | -127 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -292 -335 12.83% | -254 -297 14.39% | -218 -209 -3.98% | -130 |
|
Net income Million USD | Released Forecast Spread | -120 | -292 -322 9.24% | -254 -291 12.77% | -218 -216 -0.5% | -96,2 |
|
EPS USD | Released Forecast Spread | -5,00 | -12,4 -10,6 -17.69% | -7,13 -8,33 14.43% | -4,42 -4,36 -1.43% | -2,03 |
| Announcement Date | 08/10/21 | 22/03/22 | 16/03/23 | 05/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 16,0 12,9 24.15% | 8,43 22,7 -62.8% | 13,5 16,5 -18.38% | 13,4 12,4 8.43% | 56,2 15,3 267.82% | 41,6 22,3 86.61% | 36,0 36,9 -2.23% | 12,0 31,2 -61.4% | 10,7 15,2 -29.64% | 14,1 | 17,2 | 22,2 | 23,7 |
|
EBITDA Million USD | Released Forecast Spread | -45,8 -59,6 23.24% | -56,9 -50,4 -12.92% | -37,3 | -24,5 | -14,8 | -11,3 | |||||||
|
EBIT Million USD | Released Forecast Spread | -68,4 -79,7 14.16% | -90,6 -71,4 -26.9% | -77,0 -78,0 1.34% | -68,4 -72,2 5.33% | -27,2 -67,1 59.47% | -51,7 -63,2 18.23% | -48,0 -48,9 1.86% | -57,3 -50,0 -14.49% | -59,9 -50,8 -18.01% | -47,3 | -39,2 | -29,1 | -22,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -61,0 -78,2 22.02% | -85,7 -69,3 -23.67% | -77,4 -70,8 -9.36% | -67,9 -75,0 9.45% | -23,1 -65,9 64.86% | -47,0 -60,1 21.79% | -42,1 -50,0 15.77% | -71,6 -57,4 -24.73% | -56,8 -48,5 -17.16% | -44,9 | -34,2 | -23,6 | -16,3 |
|
Net income Million USD | Released Forecast Spread | -61,0 -73,5 17.06% | -85,7 -52,0 -64.96% | -77,4 -72,7 -6.54% | -67,9 -70,8 4.16% | -23,1 -59,8 61.33% | -47,0 -57,9 18.76% | -42,1 -51,2 17.8% | -71,6 -58,7 -22.1% | -56,8 -55,7 -1.94% | -41,0 | -29,5 | -15,3 | -10,3 |
|
EPS USD | Released Forecast Spread | -2,55 -3,15 19.05% | -3,20 -1,82 -76.15% | -2,02 -1,93 -4.66% | -1,76 -1,85 4.99% | -0,60 -1,56 61.48% | -1,08 -1,27 14.96% | -0,83 -1,07 22.43% | -1,40 -1,15 -21.48% | -1,11 -1,05 -5.97% | -0,81 | -0,63 | -0,36 | -0,27 |
| Announcement Date | 22/03/22 | 12/05/22 | 10/08/22 | 07/11/22 | 16/03/23 | 03/05/23 | 14/08/23 | 14/11/23 | 05/03/24 | - | - | - | - |
More events
Past sector events for 2seventy bio, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TSVT Stock
- Calendar 2seventy bio, Inc.
